Company
United StatesPublic company, NASDAQ: BDSXBiodesix, Inc. (NASDAQ: BDSX), Louisville, CO – FDA Inspections
Inspection records and compliance data for Biodesix, Inc. in Louisville, Colorado. 1 FDA inspection on record, last inspected April 12, 2024. Publicly traded as NASDAQ: BDSX.
Company Profile
This profile covers Biodesix, Inc. based in Louisville, Colorado, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected April 12, 2024.
Most cited issue areas
- Design history file1 inspection
- Lack of or inadequate complaint procedures1 inspection
- Lack of or inadequate procedures1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 12, 2024 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1236132 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Biodesix, Inc.
Stock ticker
BDSX
Exchange
NASDAQ
Share price
$20.00
Market cap
$211.0M
Price as of
November 6, 2026
FEI Number
3011854503
Address
919 W Dillon Rd, Louisville, Colorado 80027, United States
Country
United States
ID: d4d00f7c-a5b1-4e8a-842d-ccafc642d3c5